MktsMarkets

bioAffinity Technologies, Inc.
NASDAQ: BIAFKey statistics
BIAF News
Stories mentioning BIAF from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 1,352 | 1,593 | 1,446 | 1,269 | 1,854 | 2,208 | 2,350 | 2,398 |
| Cost of Goods Sold | ||||||||
| Gross Profit | ||||||||
| Operating Expenses | ||||||||
| Research & Development | 350.00 | 374.00 | 331.00 | 311.00 | 367.00 | 391.00 | 274.00 | 402.00 |
| Sales General & Admin | 3,242 | 3,037 | 2,209 | 2,215 | 2,453 | 2,919 | 2,365 | 2,473 |
| Total Operating Expenses | 4,969 | 4,729 | 3,739 | 3,785 | 4,481 | 5,154 | 4,324 | 4,485 |
| Operating Income (Loss) | (3,617) | (3,137) | (2,293) | (2,516) | (2,627) | (2,946) | (1,974) | (2,088) |
| Interest Income | 10.00 | 19.00 | 1.00 | 2.00 | 1.00 | 5.00 | 2.00 | 5.00 |
| Interest Expense | ||||||||
| Other Expense | 0.00 | |||||||
| Pretax Income | (3,631) | (3,134) | (5,048) | (4,032) | (2,652) | (2,967) | (1,998) | (2,105) |
| Tax Provision | 3.00 | 3.00 | 29.00 | 9.00 | 0.00 | 3.00 | 5.00 | |
| Net Income (Loss) | (3,631) | (3,138) | (5,051) | (4,061) | (2,660) | (2,967) | (2,001) | (2,110) |
| Earnings Per Share (Basic) | (0.81) | (1.82) | (4.74) | (0.17) | (4.80) | (7.34) | (4.84) | (0.19) |
| Earnings Per Share (Diluted) | (0.81) | (1.82) | (4.74) | (0.17) | (4.80) | (7.34) | (4.84) | (0.19) |
| Weighted Average Shares Outstanding (Basic) | 4,495 | 1,721 | 1,066 | 24,022 | 542.00 | 404.00 | 413.00 | 11,389 |
| Weighted Average Shares Outstanding (Diluted) | 4,495 | 1,721 | 1,066 | 24,022 | 542.00 | 404.00 | 413.00 | 11,389 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About BIAF
bioAffinity Technologies, Inc. (NASDAQ: BIAF) is a stock listed on the Nasdaq Stock Market under the ticker symbol BIAF. It last traded at $3.73 (Oct 16, 2026, 4:00 PM ET), down 5.8% on the day. That gives bioAffinity Technologies a market capitalisation of $4.8M.
Over the past 52 weeks BIAF has traded between $3.23 and $80.70.
Revenue for the quarter ended Mar 31, 2026 was $1.4M; a net loss of $3.6M. Revenue was down 27.1% from $1.9M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $1.4M | -$3.6M | -268.6% |
| Dec 31, 2025 | $1.6M | -$3.1M | -197.0% |
| Sep 30, 2025 | $1.4M | -$5.1M | -349.3% |
| Jun 30, 2025 | $1.3M | -$4.1M | -320.0% |
From bioAffinity Technologies’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…